Text Size

Be SMART NIS, Moderate to Servere Asthma Patient Observation

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00514787
First received: August 9, 2007
Last updated: March 26, 2009
Last verified: March 2009
History of Changes
  Purpose

Screen for moderate to severe asthma patients with suboptimal asthma control (as defined by GINA-Guidelines). Document current asthma control status. Re-evaluate asthma therapy and document new therapy if applicable.


Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Be SMART NIS, Moderate to Servere Asthma Patient Observation

Resource links provided by NLM:

MedlinePlus related topics: Asthma
U.S. FDA Resources

Further study details as provided by AstraZeneca:

Estimated Enrollment: 900
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Moderate to severe asthma with suboptimal control

Exclusion Criteria:

  • Intermittent or mild asthma, patient with good asthma control
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00514787

Locations
Austria
Research Site
Vienna, Austria
Sponsors and Collaborators
AstraZeneca
Investigators
Study Chair: Wolfgang Pohl, PHD Executive Board OGP (Austria Society of Pneumology
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00514787     History of Changes
Other Study ID Numbers: NIS-RAT-SYM-2007/1
Study First Received: August 9, 2007
Last Updated: March 26, 2009
Health Authority: Austria: Agency for Health and Food Safety

Keywords provided by AstraZeneca:
Asthma
NIS

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
 Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 19, 2013